<!DOCTYPE html>

<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>WAAMS - Western Australia AntiMicrobial Stewardship</title>
    <link rel="shortcut icon" type="image/ico" href="favicon.ico" />
    <link rel="apple-touch-icon" href="apple-touch-icon-precomposed.png">
    <link rel="apple-touch-icon-precomposed" href="apple-touch-icon-precomposed.png">
    <link rel="stylesheet" href="bootstrap/css/bootstrap.min.css" />
    <link rel="stylesheet" href="bootstrap/css/bootstrap-theme.min.css" />
    <link rel="stylesheet" href="bootstrap/css/basic.css" />
    <link rel="stylesheet" href="bootstrap/css/style.css" />
    <script src="bootstrap/js/jquery-1.11.1.min.js"></script>
    <script type="text/javascript" src="bootstrap/js/codecheckWA.js"></script>
    <!-- Needed for Forms Feature Detection -->
    <script src="polyfill/better-dom.min.js"></script>
    <!-- Needed for Validation -->
    <script src="polyfill/better-dateinput-polyfill.js"></script>
    <script src="polyfill/ie-array-polyfill.js"></script>
    <!-- General helpful functions -->
    <script src="bootstrap/js/kraken.js"></script>
</head>

<body>

    <!-- loading page -->
    <div data-role="page" id="load" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Loading</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Loading</span>
            </h3>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /load -->

    <!-- LET THE OPEN FRACTURE MAZE BEGIN!! -->
    <!-- Start of OPEN page prophylaxis or treatment?: #open -->
    <div data-role="page" id="open" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Open fracture</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is there clinical evidence of infection?</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#open1">No, &#40;prophylaxis is required&#41;</a></li>
                <li><a href="#open2">Yes, &#40;established infection is present&#41;</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>If the wound is contaminated with soil or faeces &#40;such as with farm injuries&#41; or has been in
                    contact with fresh or salt water then infectious diseases should be contacted immediately for
                    targeted treatment. </li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /open -->


    <!-- Start of open page: prophylaxis #open -->
    <div data-role="page" id="open1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Open fracture</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#open1a">No penicillin allergy</a></li>
                <li><a href="#open1a">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#open1c">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patientâ€™s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /open1 -->

    <!-- Start of open page, treatment: #open2 -->
    <div data-role="page" id="open2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Open fracture</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#open2a">No penicillin allergy</a></li>
                <li><a href="#open2b">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#open2c">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patientâ€™s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /open2 -->

    <!-- Start of OPEN page, prophylaxis, Pen OK or MILD, : #open1a -->
    <div data-role="page" id="open1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Open fracture prophylaxis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If there is serious tissue damage or clinical evidence of infection
                    give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Cefazolin 2 g &#40;child: 50 mg/kg up
                        to 2 g&#41; IV, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> If the wound has been immersed in water &#40;eg injuries sustained in a
                    natural disaster, marine injuries&#41;</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Cefepime 2 g &#40;child: 50 mg/kg up
                        to 2 g&#41; IV, 8-hourly</span>
                </h4>
                <p class="mrgn20b">For a maximum of 3 days &#40;longer if there is evidence of established
                    infection&#41;</p>
            </div>
            <p class="mrgn20b"><b>AND</b> If the wound is heavily contaminated with material embedded in bone or deep
                soft tissues &#40;eg agriculture injuries, injuries involving sewage&#41; <b>ADD</b></p>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg &#40;child: 12.5 mg/kg up to 500 mg&#41; IV,
                        12-hourly</span>
                </h4>
                <p class="mrgn20b">For a maximum of 3 days &#40;longer if there is evidence of established
                    infection&#41;</p>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefepime is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>opf</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Regardless of injury severity, the total duration of prophylaxis should be no more than 72 hours,
                    even if soft tissue coverage is not achievable.</li>
                <li>Prophylaxis for nonsevere injuries comparable to Gustiloâ€“Anderson type I or II &#40;open fractures
                    resulting from indirect injury or direct, low-energy injury&#41; can be discontinued at definitive
                    wound closure.</li>
                <li>If there is likely to be a delay in accessing cefepime, give an immediate dose of cefazolin &#40;as
                    above&#41;, because the benefit of prophylaxis is greatest when it is given immediately after
                    injury. Switch to cefepime as soon as it is available.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on open fractures</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /open1a -->

    <!-- Start of OPEN page Pen BAD, prophylaxis: #open1c -->
    <div data-role="page" id="open1c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Open fracture prophylaxis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient has immediate severe penicillin hypersensitivity give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg &#40;child: 15 mg/kg up to 600 mg&#41; IV,
                        8-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> if the wound has been immersed in water <b>ADD</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 400 mg &#40;child: 10 mg/kg up to 400 mg&#41; IV,
                        8-hourly</span>
                </h4>
                <p class="mrgn20b">For a maximum of 3 days &#40;longer if there is evidence of established
                    infection&#41; this code is valid for both IV or oral ciprofloxacin and clindamycin</p>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ciprofloxacin and clindamycin iv is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>opf</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if IV treatment is to continue past 72 hours.
                    Please annotate this code on the medication chart and document when infectious diseases are to be
                    contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Regardless of injury severity, the total duration of prophylaxis should be no more than 72 hours,
                    even if soft tissue coverage is not achievable.</li>
                <li>Prophylaxis for nonsevere injuries comparable to Gustiloâ€“Anderson type I or II &#40;open fractures
                    resulting from indirect injury or direct, low-energy injury&#41; can be discontinued at definitive
                    wound closure.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See the section on open fractures</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /open1c -->


    <!-- Start of OPEN page Pen OK, TREATMENT, : #open2a -->
    <div data-role="page" id="open2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Open fracture treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If treating established infection with no penicillin allergy give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin+tazobactam 4+0.5 g &#40;child: 100+12.5 mg/kg up to 4+0.5
                        g&#41; IV, 6-hourly</span>
                </h4>
            </div>
            <p class="mrgn20b"><b>OR</b> if the wound has been immersed in water, replace piperacillin+tazobactam with:
            </p>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefepime 2 g &#40;child: 50 mg/kg up to 2 g&#41; IV, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg &#40;child: 12.5 mg/kg up to 500 mg&#41; IV,
                        12-hourly</span>
                </h4>
            </div>
            <p class="mrgn20b"><b>AND</b> with either of the above regimens, if the patient has sepsis or septic shock,
                or is at increased risk of MRSA <b>ADD</b></p>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, with a loading dose of 25-30 mg/kg, then dosed as per the
                        nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for
                            adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin or cefepime is:</span>
                <span class="font15 bold"> 7<script> document.write(getCode())</script>opc</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past one week. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>opc</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Patients with severe tissue damage or evidence of infection all need presumptive treatment for 7
                    days total. Patients with established bone infection usually require a longer duration of IV
                    antibiotic therapy followed by oral continuation therapy</li>
                <li>There is no advantage of continuing prophylaxis beyond 72 hours in the absence of infection even if
                    wound closure has not been achieved</li>
            </ul>
            <hr>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See the section on open fractures</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /open2a -->

    <!-- Start of OPEN page Pen MILD, TREATMENT, : #open2b -->
    <div data-role="page" id="open2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Open fracture treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If treating established infection with delayed penicillin hypersensitivity
                    give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefepime 2 g &#40;child: 50 mg/kg up to 2 g&#41; IV, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg &#40;child: 12.5 mg/kg up to 500 mg&#41; IV,
                        12-hourly</span>
                </h4>
            </div>
            <p class="mrgn20b"><b>AND</b> with the above regimen, if the patient has sepsis or septic shock, or is at
                increased risk of MRSA <b>ADD</b></p>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, with a loading dose of 25-30 mg/kg, then dosed as per the
                        nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for
                            adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefepime is:</span>
                <span class="font15 bold"> 7<script> document.write(getCode())</script>opc</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past one week. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>opc</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Patients with severe tissue damage or evidence of infection all need presumptive treatment for 7
                    days total. Patients with established bone infection usually require a longer duration of IV
                    antibiotic therapy followed by oral continuation therapy</li>
                <li>There is no advantage of continuing prophylaxis beyond 72 hours in the absence of infection even if
                    wound closure has not been achieved</li>
            </ul>
            <hr/>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See the section on open fractures</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /open2a -->


    <!-- Start of OPEN page Pen BAD, TREATMENT: #open2c -->
    <div data-role="page" id="open2c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Open Fracture Treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient has immediate severe penicillin hypersensitivity give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg &#40;child: 15 mg/kg up to 600 mg&#41; IV,
                        8-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 400 mg &#40;child: 10 mg/kg up to 400 mg&#41; IV,
                        8-hourly</span>
                </h4>
            </div>
            <p class="mrgn20b"><b>AND</b> with the above regimen, if the patient has sepsis or septic shock, or is at
                increased risk of MRSA <b>ADD</b></p>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, with a loading dose of 25-30 mg/kg, then dosed as per the
                        nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for
                            adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ciprofloxacin and clindamycin iv is:</span>
                <span class="font15 bold"> 7<script> document.write(getCode())</script>opf</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>SEVEN</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if IV treatment is to continue past one week.
                    Please annotate this code on the medication chart and document when infectious diseases are to be
                    contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>opc</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul type="circle" class="line30">
                <li>Prophylaxis for nonsevere injuries comparable to Gustiloâ€“Anderson type I or II &#40;open fractures
                    resulting from indirect injury or direct, low-energy injury&#41; can be discontinued at definitive
                    wound closure.</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /open2c -->

    <!-- END OF OPEN FRACTURES MAZE -->

    <!-- START OF OSTEOMYELITIS MAZE -->

    <!-- Start of osteomyelitis page: ?allergy -->
    <div data-role="page" id="osteo" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Osteomyelitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">See below for details on penicillin allergy severity</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#osteo1">No penicillin allergy</a></li>
                <li><a href="#osteo2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#osteo3">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary">History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patientâ€™s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteo page: no pen allergy ?adult -->
    <div data-role="page" id="osteo1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Osteomyelitis with no penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient an adult or a child?</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#osteo1a">Adult</a></li>
                <li><a href="#osteo1b">Child &lt; 12 years</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>For treatment of osteomyelitis in a neonate please contact infectious diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo1 -->


    <!-- Start of osteo page: mild pen allergy ?adult -->
    <div data-role="page" id="osteo2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Osteomyelitis with non-severe penicillin hypersensitivity</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient an adult or a child?</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#osteo2a">Adult</a></li>
                <li><a href="#osteo2b">Child &lt; 12 years</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>For treatment of osteomyelitis in a neonate please contact infectious diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->


    <!-- Start of osteo page: BAD pen allergy ?adult -->
    <div data-role="page" id="osteo3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Osteomyelitis with severe penicillin reaction</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient an adult or a child?</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#osteo3a">Adult</a></li>
                <li><a href="#osteo3b">Child &lt; 12 years</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>For treatment of osteomyelitis in a neonate please contact infectious diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteo page: NO penicillin allergy, child ?MRSA -->
    <div data-role="page" id="osteo1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Child osteomyelitis with no penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#osteo1b1">Yes</a></li>
                <li><a href="#osteo1b2">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous
                    heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteo page: MILD penicillin allergy, child ?MRSA -->
    <div data-role="page" id="osteo2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Child osteomyelitis with no penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#osteo1b1">Yes</a></li>
                <li><a href="#osteo2b2">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous
                    heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteo page: no pen allergy, adult, ?type -->
    <div data-role="page" id="osteo1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult osteomyelitis with no penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Where is the osteomyelitis located?</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#osteo1a1">Leg or foot ulcer</a></li>
                <li><a href="#osteo1a2">Vertebral bone</a></li>
                <li><a href="#osteo1a3">Long bone</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteo page: no pen allergy, adult, ?type -->
    <div data-role="page" id="osteo1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult osteomyelitis with no penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient showing signs of sepsis?</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="skinNsoftTissue.html#diabf3c1">Yes, (treat as diabetic foot)</a></li>
                <li><a href="#osteo1a1b">No</a></li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Signs of Sepsis:</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>SIRS response: &ge;2 of:</th>
                        <th>AND presence of refractory hypotension or hypoperfusion</th>
                    </tr>
                    <tr>
                        <td>
                            <p>Temp &lt;36 <b>or</b> &gt;38</p>
                            <p>Heart rate &gt; 90</p>
                            <p>Resp Rate &gt; 20</p>
                            <p>WCC &gt; 12.0 <b>or</b> &lt; 4.0</p>
                        </td>
                        <td>
                            <p align="left"><b>Hypotension:</b></p>
                            <ul type=circle>
                                <li>systolic BP&lt; 90 mmHg <b>OR</b> 40 mmHg below premorbid BP <b> AFTER</b> at least
                                    500 mL fluid challenge.</li>
                            </ul>
                            <p align="left"><b>Hypoperfusion:</b></p>
                            <ul type=circle>
                                <li>Lactate &ge;4 mmol/L <b>OR</b> Bicarbonate &lt;16mmol/L</li>
                            </ul>
                        </td>
                    </tr>
                </table>
            </div>
            <ul class="line30">
                <li>See the management of severe sepsis section in the Australian Therapeutic Guidelines for more
                    information on identifying a septic patient</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteo page: no pen allergy, adult, ?type -->
    <div data-role="page" id="osteo2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult osteomyelitis with non-severe penicillin hypersensitivity</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Where is the osteomyelitis located?</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="skinNsoftTissue.html#diabf1c1">Leg or foot ulcer &#40;treat as diabetic foot&#41;</a></li>
                <li><a href="#osteo2a2">Vertebral bone</a></li>
                <li><a href="#osteo2a3">Long bone</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteo page: no pen allergy, adult, ?type -->
    <div data-role="page" id="osteo3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult osteomyelitis with severe penicillin hypersensitivity</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Where is the osteomyelitis located?</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="skinNsoftTissue.html#diabf1c1">Leg or foot ulcer &#40;treat as diabetic foot&#41;</a></li>
                <li><a href="#osteo3a2">Vertebral bone</a></li>
                <li><a href="#osteo3a3">Long bone</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteo page: no pen allergy, adult, vertebral, ?neurological compromise -->
    <div data-role="page" id="osteo1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult vertebral osteomyelitis with no penicillin hypersensitivity</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have signs of compromise after neurological examination?
                    &#40;see below&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#osteo1a2a">Yes, neurological compromise present</a></li>
                <li><a href="#osteo1a2b">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Select yes if the patient has either signs of neurological compromise, or spinal, paraspinal or
                    epidural spinal abscess</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteo page: no pen allergy, adult, vertebral, ?neurological compromise -->
    <div data-role="page" id="osteo2a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult vertebral osteomyelitis with non-severe penicillin hypersensitivity</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have signs of compromise after neurological examination?
                    &#40;see below&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#osteo2a2a">Yes, neurological compromise present</a></li>
                <li><a href="#osteo2a2b">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Select yes if the patient has either signs of neurological compromise, or spinal, paraspinal or
                    epidural spinal abscess</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteo page: no pen allergy, adult, vertebral, ?neurological compromise -->
    <div data-role="page" id="osteo3a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult vertebral osteomyelitis with severe penicillin hypersensitivity</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have signs of compromise after neurological examination?
                    &#40;see below&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#osteo3a2a">Yes, neurological compromise present</a></li>
                <li><a href="#osteo3a2b">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Select yes if the patient has either signs of neurological compromise, or spinal, paraspinal or
                    epidural spinal abscess</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteo page: no penicillin allergy, adult, vertebral, not neurological ?MRSA -->
    <div data-role="page" id="osteo1a2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult vertebral osteomyelitis with no penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#osteox">Yes</a></li>
                <li><a href="#osteo1a2b2">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous
                    heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteo page: no penicillin allergy, adult, not neurological, vertebral, ?MRSA -->
    <div data-role="page" id="osteo2a2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult vertebral osteomyelitis with non-severe penicillin hypersensitivity</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#osteox">Yes</a></li>
                <li><a href="#osteo2a2b2">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous
                    heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteo page: no penicillin allergy, adult, vertebral, not neurological ?MRSA -->
    <div data-role="page" id="osteo3a2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult vertebral osteomyelitis with severe penicillin reaction</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#osteox">Yes</a></li>
                <li><a href="#osteo3a2b2">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous
                    heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteo page: no penicillin allergy, adult, long bone ?MRSA -->
    <div data-role="page" id="osteo1a3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult long bone osteomyelitis with no penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#osteo3a3">Yes</a></li>
                <li><a href="#osteo1a3b">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous
                    heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteo page: mild penicillin allergy, adult, vertebral, not neurological ?MRSA -->
    <div data-role="page" id="osteo2a3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult long bone osteomyelitis with non-severe penicillin hypersensitivity</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#osteo3a3">Yes</a></li>
                <li><a href="#osteo2a3b">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous
                    heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of Osteo, Pen OK, KID, YES MRSA: -->
    <div data-role="page" id="osteo1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>
        <div data-role="header" class="secondpage">
            <h1>Osteomyelitis:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For osteomyelitis treatment in a child with non-severe or no penicillin
                    hypersensitivity, at risk of MRSA give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin, as per the nomogram below</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b> if <i>Kingella kingae</i> is proven or suspected &#40;see below&#41;
                    <b>ADD</b> either:</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Cefotaxime 50 mg/kg up to 2 g
                        intravenously, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ceftriaxone 50 mg/kg up to 2 g
                        intravenously, daily</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>ost</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefotaxime or ceftriaxone is:</span>
                <span class="font15 bold"> 5<script> document.write(getCode())</script>ost</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>FIVE</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past five days. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr />
            <ul class="line30">
                <li>This regimen is for both acute and chronic osteomyelitis until a microbiological diagnosis is made.
                    Obtain diagnostic samples before antibiotic therapy is started. Once a microbiological diagnosis is
                    made, modify therapy accordingly</li>
                <li>If the patient is septic please treat as per <a href="sepsisNsimilar.html#sepsis">sepsis</a>
                    treatment pathway</li>
                <li><i>K. kingae</i> infections can be comcomitant with upper respiratory diseases or stomatitis, since
                    disrupted respiratory or buccal mucosa is likely to facilitate bacterial invasion and hematogenous
                    dissemination. <i>K. kingae</i> should be considered in children younger than 4 years who fail to
                    improve rapidly with antistaphylococcal therapy</li>
                <li>For adults or children with osteomyelitis associated with prosthetic material, seek expert advice
                </li>
                <li>Prolonged antibiotic therapy is required to cure osteomyelitis. The duration of therapy depends on
                    the patientâ€™s age, whether the infection is acute or chronic, the pathogen and the patientâ€™s
                    clinical response. Intravenous antibiotic therapy is almost always required initially, but oral
                    antibiotic therapy is usually preferred to complete the treatment course</li>
                <li>Children usually require a shorter duration of therapy than adults because their bones have an
                    excellent blood supply. Intravenous therapy should generally be continued until blood culture
                    results are negative, the child is afebrile and has clinically improved, and C-reactive protein
                    (CRP) or erythrocyte sedimentation rate (ESR) is decreasing</li>
                <li>To cure chronic osteomyelitis, surgical debridement of necrotic bone and sequestra is essential</li>
                <li>Collect blood samples for culture because more than 50% of patients with vertebral or acute
                    long-bone osteomyelitis have bacteraemia. To increase blood culture yield, adults should have two
                    sets of samples (ie four bottles) collected. If blood culture results are positive, bone biopsy is
                    generally unnecessary. However, if no organism, or an organism of questionable significance (eg a
                    commensal organism such as a coagulase-negative staphylococcus), is identified, it is critical to
                    collect suitable samples of bone or pus for culture and histopathology. These samples should be
                    collected by radiologically guided percutaneous or open biopsy. In children, bone biopsy is not
                    required if there is a good response to empirical antibiotic therapy, even if blood culture results
                    are negative</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ol>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on osteomyelitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of Osteo, Pen OK, KID, NO MRSA: -->
    <div data-role="page" id="osteo1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>
        <div data-role="header" class="secondpage">
            <h1>Osteomyelitis:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For osteomyelitis treatment in a child with no penicillin hypersensitivity,
                    not at risk of MRSA give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Flucloxacillin 50 mg/kg up to 2 g intravenously, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b> if <i>Kingella kingae</i> is proven or suspected &#40;see below&#41;
                    <b>ADD</b> either:</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Cefotaxime 50 mg/kg up to 2 g
                        intravenously, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ceftriaxone 50 mg/kg up to 2 g
                        intravenously, daily</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefotaxime or ceftriaxone is:</span>
                <span class="font15 bold"> 5<script> document.write(getCode())</script>ost</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>FIVE</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past five days. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr />
            <ul class="line30">
                <li>This regimen is for both acute and chronic osteomyelitis until a microbiological diagnosis is made.
                    Obtain diagnostic samples before antibiotic therapy is started. Once a microbiological diagnosis is
                    made, modify therapy accordingly</li>
                <li>If the patient is septic please treat as per <a href="sepsisNsimilar.html#sepsis">sepsis</a>
                    treatment pathway</li>
                <li><i>K. kingae</i> infections can be comcomitant with upper respiratory diseases or stomatitis, since
                    disrupted respiratory or buccal mucosa is likely to facilitate bacterial invasion and hematogenous
                    dissemination. <i>K. kingae</i> should be considered in children younger than 4 years who fail to
                    improve rapidly with antistaphylococcal therapy</li>
                <li>For adults or children with osteomyelitis associated with prosthetic material, seek expert advice
                </li>
                <li>Prolonged antibiotic therapy is required to cure osteomyelitis. The duration of therapy depends on
                    the patientâ€™s age, whether the infection is acute or chronic, the pathogen and the patientâ€™s
                    clinical response. Intravenous antibiotic therapy is almost always required initially, but oral
                    antibiotic therapy is usually preferred to complete the treatment course</li>
                <li>Children usually require a shorter duration of therapy than adults because their bones have an
                    excellent blood supply. Intravenous therapy should generally be continued until blood culture
                    results are negative, the child is afebrile and has clinically improved, and C-reactive protein
                    (CRP) or erythrocyte sedimentation rate (ESR) is decreasing</li>
                <li>To cure chronic osteomyelitis, surgical debridement of necrotic bone and sequestra is essential</li>
                <li>Collect blood samples for culture because more than 50% of patients with vertebral or acute
                    long-bone osteomyelitis have bacteraemia. To increase blood culture yield, adults should have two
                    sets of samples (ie four bottles) collected. If blood culture results are positive, bone biopsy is
                    generally unnecessary. However, if no organism, or an organism of questionable significance (eg a
                    commensal organism such as a coagulase-negative staphylococcus), is identified, it is critical to
                    collect suitable samples of bone or pus for culture and histopathology. These samples should be
                    collected by radiologically guided percutaneous or open biopsy. In children, bone biopsy is not
                    required if there is a good response to empirical antibiotic therapy, even if blood culture results
                    are negative</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on osteomyelitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of Osteo, Pen OK, KID, NO MRSA: -->
    <div data-role="page" id="osteo2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>
        <div data-role="header" class="secondpage">
            <h1>Osteomyelitis:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For osteomyelitis treatment in a child with non-severe penicillin
                    hypersensitivity, not at risk of MRSA give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefazolin 50 mg/kg up to 2 g intravenously, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b> if <i>Kingella kingae</i> is proven or suspected &#40;see below&#41;
                    <b>ADD</b> either:</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Cefotaxime 50 mg/kg up to 2 g
                        intravenously, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ceftriaxone 50 mg/kg up to 2 g
                        intravenously, daily</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefotaxime or ceftriaxone is:</span>
                <span class="font15 bold"> 5<script> document.write(getCode())</script>ost</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>FIVE</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past five days. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr />
            <ul class="line30">
                <li>This regimen is for both acute and chronic osteomyelitis until a microbiological diagnosis is made.
                    Obtain diagnostic samples before antibiotic therapy is started. Once a microbiological diagnosis is
                    made, modify therapy accordingly</li>
                <li>If the patient is septic please treat as per <a href="sepsisNsimilar.html#sepsis">sepsis</a>
                    treatment pathway</li>
                <li><i>K. kingae</i> infections can be comcomitant with upper respiratory diseases or stomatitis, since
                    disrupted respiratory or buccal mucosa is likely to facilitate bacterial invasion and hematogenous
                    dissemination. <i>K. kingae</i> should be considered in children younger than 4 years who fail to
                    improve rapidly with antistaphylococcal therapy</li>
                <li>For adults or children with osteomyelitis associated with prosthetic material, seek expert advice
                </li>
                <li>Prolonged antibiotic therapy is required to cure osteomyelitis. The duration of therapy depends on
                    the patientâ€™s age, whether the infection is acute or chronic, the pathogen and the patientâ€™s
                    clinical response. Intravenous antibiotic therapy is almost always required initially, but oral
                    antibiotic therapy is usually preferred to complete the treatment course</li>
                <li>Children usually require a shorter duration of therapy than adults because their bones have an
                    excellent blood supply. Intravenous therapy should generally be continued until blood culture
                    results are negative, the child is afebrile and has clinically improved, and C-reactive protein
                    (CRP) or erythrocyte sedimentation rate (ESR) is decreasing</li>
                <li>To cure chronic osteomyelitis, surgical debridement of necrotic bone and sequestra is essential</li>
                <li>Collect blood samples for culture because more than 50% of patients with vertebral or acute
                    long-bone osteomyelitis have bacteraemia. To increase blood culture yield, adults should have two
                    sets of samples (ie four bottles) collected. If blood culture results are positive, bone biopsy is
                    generally unnecessary. However, if no organism, or an organism of questionable significance (eg a
                    commensal organism such as a coagulase-negative staphylococcus), is identified, it is critical to
                    collect suitable samples of bone or pus for culture and histopathology. These samples should be
                    collected by radiologically guided percutaneous or open biopsy. In children, bone biopsy is not
                    required if there is a good response to empirical antibiotic therapy, even if blood culture results
                    are negative</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on osteomyelitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of Osteo, Pen OK, KID, YES MRSA: -->
    <div data-role="page" id="osteo3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <h1>WAAMS - Western Australia AntiMicrobial Stewardship</h1>
        </div>
        <div data-role="header" class="secondpage">
            <h1>Osteomyelitis:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For osteomyelitis treatment in a child with severe penicillin
                    hypersensitivity:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin, as per the nomogram below</span>
                </h4>
                <h4 class="color-danger mrgn15b"> Please contact infectious diseases if <i>Kingella kingae</i> is proven
                    or suspected &#40;see below&#41;</h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>ost</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>This regimen is for both acute and chronic osteomyelitis until a microbiological diagnosis is made.
                    Obtain diagnostic samples before antibiotic therapy is started. Once a microbiological diagnosis is
                    made, modify therapy accordingly</li>
                <li>If the patient is septic please treat as per <a href="sepsisNsimilar.html#sepsis">sepsis</a>
                    treatment pathway</li>
                <li><i>K. kingae</i> infections can be comcomitant with upper respiratory diseases or stomatitis, since
                    disrupted respiratory or buccal mucosa is likely to facilitate bacterial invasion and hematogenous
                    dissemination. <i>K. kingae</i> should be considered in children younger than 4 years who fail to
                    improve rapidly with antistaphylococcal therapy</li>
                <li>For adults or children with osteomyelitis associated with prosthetic material, seek expert advice
                </li>
                <li>Prolonged antibiotic therapy is required to cure osteomyelitis. The duration of therapy depends on
                    the patientâ€™s age, whether the infection is acute or chronic, the pathogen and the patientâ€™s
                    clinical response. Intravenous antibiotic therapy is almost always required initially, but oral
                    antibiotic therapy is usually preferred to complete the treatment course</li>
                <li>Children usually require a shorter duration of therapy than adults because their bones have an
                    excellent blood supply. Intravenous therapy should generally be continued until blood culture
                    results are negative, the child is afebrile and has clinically improved, and C-reactive protein
                    (CRP) or erythrocyte sedimentation rate (ESR) is decreasing</li>
                <li>To cure chronic osteomyelitis, surgical debridement of necrotic bone and sequestra is essential</li>
                <li>Collect blood samples for culture because more than 50% of patients with vertebral or acute
                    long-bone osteomyelitis have bacteraemia. To increase blood culture yield, adults should have two
                    sets of samples (ie four bottles) collected. If blood culture results are positive, bone biopsy is
                    generally unnecessary. However, if no organism, or an organism of questionable significance (eg a
                    commensal organism such as a coagulase-negative staphylococcus), is identified, it is critical to
                    collect suitable samples of bone or pus for culture and histopathology. These samples should be
                    collected by radiologically guided percutaneous or open biopsy. In children, bone biopsy is not
                    required if there is a good response to empirical antibiotic therapy, even if blood culture results
                    are negative</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ol>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on osteomyelitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteomyelitis, adult, no pen all, long bone, MRSA negative -->
    <div data-role="page" id="osteo1a3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult long bone osteomyelitis with no MRSA or penicillin allergy</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn20">Adult long bone osteomyelitis with no MRSA or penicillin allergy should be
                treated with:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Flucloxacillin 2 g IV, 6-hourly.</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>This regimen is for both acute and chronic osteomyelitis until a microbiological diagnosis is made.
                    Obtain diagnostic samples before antibiotic therapy is started. Once a microbiological diagnosis is
                    made, modify therapy accordingly</li>
                <li>If the patient is septic please treat as per <a href="sepsisNsimilar.html#sepsis">sepsis</a>
                    treatment pathway</li>
                <li>For adults or children with osteomyelitis associated with prosthetic material, seek expert advice
                </li>
                <li>Prolonged antibiotic therapy is required to cure osteomyelitis. The duration of therapy depends on
                    the patientâ€™s age, whether the infection is acute or chronic, the pathogen and the patientâ€™s
                    clinical response. Intravenous antibiotic therapy is almost always required initially, but oral
                    antibiotic therapy is usually preferred to complete the treatment course</li>
                <li>To cure chronic osteomyelitis, surgical debridement of necrotic bone and sequestra is essential</li>
                <li>Collect blood samples for culture because more than 50% of patients with vertebral or acute
                    long-bone osteomyelitis have bacteraemia. To increase blood culture yield, adults should have two
                    sets of samples (ie four bottles) collected. If blood culture results are positive, bone biopsy is
                    generally unnecessary. However, if no organism, or an organism of questionable significance (eg a
                    commensal organism such as a coagulase-negative staphylococcus), is identified, it is critical to
                    collect suitable samples of bone or pus for culture and histopathology. These samples should be
                    collected by radiologically guided percutaneous or open biopsy.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on osteomyelitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of hap Tx MILD, PEN OK: #osteo1a1b -->
    <div data-role="page" id="osteo1a1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult leg or foot osteomyelitis (non-diabetic)</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient tolerates penicillin use as a single agent:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17"><span class="color-purple"> Amoxicillin + clavulanate
                            intravenously</span></span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">1 + 0.2 g 8-hourly, </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and less than 4kg: &nbsp;</span>
                                </td>
                                <td><span class="color-purple"> 25 + 5 mg/kg 12-hourly,</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and 4kg or more, or 3 months or
                                        older: &nbsp;</span></td>
                                <td><span class="color-purple"> 25 + 5 mg/kg (up to 1 + 0.2g) 8-hourly</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for Amoxicillin IV & Clavulanate is:</span>
                <span class="font15 bold"> 5<script> document.write(getCode())</script>ost</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FIVE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past five days. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>This regimen will not cover MRSA. Risk factors for MRSA infection include: residence in a jail or
                    detention centre, indigenous heritage, previous MRSA colonisation and line associated infection.
                    Contact infectious diseases if MRSA infection is suspected</li>
                <li>This regimen is for both acute and chronic osteomyelitis until a microbiological diagnosis is made.
                    Obtain diagnostic samples before antibiotic therapy is started. Once a microbiological diagnosis is
                    made, modify therapy accordingly</li>
                <li>If the patient is septic please treat as per <a href="sepsisNsimilar.html#sepsis">sepsis</a>
                    treatment pathway</li>
                <li>For adults or children with osteomyelitis associated with prosthetic material, seek expert advice
                </li>
                <li>Prolonged antibiotic therapy is required to cure osteomyelitis. The duration of therapy depends on
                    the patientâ€™s age, whether the infection is acute or chronic, the pathogen and the patientâ€™s
                    clinical response. Intravenous antibiotic therapy is almost always required initially, but oral
                    antibiotic therapy is usually preferred to complete the treatment course</li>
                <li>To cure chronic osteomyelitis, surgical debridement of necrotic bone and sequestra is essential</li>
                <li>Collect blood samples for culture because more than 50% of patients with vertebral or acute
                    long-bone osteomyelitis have bacteraemia. To increase blood culture yield, adults should have two
                    sets of samples (ie four bottles) collected. If blood culture results are positive, bone biopsy is
                    generally unnecessary. However, if no organism, or an organism of questionable significance (eg a
                    commensal organism such as a coagulase-negative staphylococcus), is identified, it is critical to
                    collect suitable samples of bone or pus for culture and histopathology. These samples should be
                    collected by radiologically guided percutaneous or open biopsy.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on osteomyelitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo1a1b -->


    <!-- Start of osteomyelitis, adult, MILD pen all, long bone, MRSA negative -->
    <div data-role="page" id="osteo2a3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult long bone osteomyelitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn20">Adult long bone osteomyelitis with no MRSA and non-severe penicillin
                hypersensitivity should be treated with:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefazolin 2 g intravenously, 8-hourly</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>This regimen is for both acute and chronic osteomyelitis until a microbiological diagnosis is made.
                    Obtain diagnostic samples before antibiotic therapy is started. Once a microbiological diagnosis is
                    made, modify therapy accordingly</li>
                <li>If the patient is septic please treat as per <a href="sepsisNsimilar.html#sepsis">sepsis</a>
                    treatment pathway</li>
                <li>For adults or children with osteomyelitis associated with prosthetic material, seek expert advice
                </li>
                <li>Prolonged antibiotic therapy is required to cure osteomyelitis. The duration of therapy depends on
                    the patientâ€™s age, whether the infection is acute or chronic, the pathogen and the patientâ€™s
                    clinical response. Intravenous antibiotic therapy is almost always required initially, but oral
                    antibiotic therapy is usually preferred to complete the treatment course</li>
                <li>To cure chronic osteomyelitis, surgical debridement of necrotic bone and sequestra is essential</li>
                <li>Collect blood samples for culture because more than 50% of patients with vertebral or acute
                    long-bone osteomyelitis have bacteraemia. To increase blood culture yield, adults should have two
                    sets of samples (ie four bottles) collected. If blood culture results are positive, bone biopsy is
                    generally unnecessary. However, if no organism, or an organism of questionable significance (eg a
                    commensal organism such as a coagulase-negative staphylococcus), is identified, it is critical to
                    collect suitable samples of bone or pus for culture and histopathology. These samples should be
                    collected by radiologically guided percutaneous or open biopsy.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on osteomyelitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteomyelitis, adult, bad pen all, OR MRSA, long bone, -->
    <div data-role="page" id="osteo3a3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult long bone osteomyelitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn20">Adult long bone osteomyelitis with MRSA or severe penicillin
                hypersensitivity treat with:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per the nomogram below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>ost</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>This regimen is for both acute and chronic osteomyelitis until a microbiological diagnosis is made.
                    Obtain diagnostic samples before antibiotic therapy is started. Once a microbiological diagnosis is
                    made, modify therapy accordingly</li>
                <li>If the patient is septic please treat as per <a href="sepsisNsimilar.html#sepsis">sepsis</a>
                    treatment pathway</li>
                <li>For adults or children with osteomyelitis associated with prosthetic material, seek expert advice
                </li>
                <li>Prolonged antibiotic therapy is required to cure osteomyelitis. The duration of therapy depends on
                    the patientâ€™s age, whether the infection is acute or chronic, the pathogen and the patientâ€™s
                    clinical response. Intravenous antibiotic therapy is almost always required initially, but oral
                    antibiotic therapy is usually preferred to complete the treatment course</li>
                <li>To cure chronic osteomyelitis, surgical debridement of necrotic bone and sequestra is essential</li>
                <li>Collect blood samples for culture because more than 50% of patients with vertebral or acute
                    long-bone osteomyelitis have bacteraemia. To increase blood culture yield, adults should have two
                    sets of samples (ie four bottles) collected. If blood culture results are positive, bone biopsy is
                    generally unnecessary. However, if no organism, or an organism of questionable significance (eg a
                    commensal organism such as a coagulase-negative staphylococcus), is identified, it is critical to
                    collect suitable samples of bone or pus for culture and histopathology. These samples should be
                    collected by radiologically guided percutaneous or open biopsy.</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Actual body<br> weight &#40;kg&#41;</th>
                        <th>CrClr <br>&lt; 20 mL/min</th>
                        <th>CrClr <br>20-60 mL/min</th>
                        <th>CrClr <br>&gt; 60 mL/min</th>
                        <th class="bg-success">Administer over<sup>(1)</sup></th>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on osteomyelitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteomyelitis, adult, no pen all, VERTEBRAL, MRSA negative -->
    <div data-role="page" id="osteo1a2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult vertebral osteomyelitis with no MRSA or penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn20">Adult vertebral osteomyelitis with no MRSA or penicillin allergy and normal
                neurological examination should be treated with:</h3>
            <h4 class="mrgn20b biteSpecial">
                <span class="font15">Withhold antibiotic therapy until a microbiological diagnosis is made in all adults
                    who have a normal neurological examination. <br><br> Only treat empirically with the treatment below
                    if microbiological diagnosis cannot be made.
                </span>
            </h4>
            <br>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Flucloxacillin 2 g IV, 6-hourly.</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>Contact infectious diseases if the patient has suspected gram negative infection</li>
                <li>This regimen is for both acute and chronic osteomyelitis until a microbiological diagnosis is made.
                    Obtain diagnostic samples before antibiotic therapy is started. Once a microbiological diagnosis is
                    made, modify therapy accordingly</li>
                <li>If the patient is septic please treat as per <a href="sepsisNsimilar.html#sepsis">sepsis</a>
                    treatment pathway</li>
                <li>For adults or children with osteomyelitis associated with prosthetic material, seek expert advice
                </li>
                <li>Prolonged antibiotic therapy is required to cure osteomyelitis. The duration of therapy depends on
                    the patientâ€™s age, whether the infection is acute or chronic, the pathogen and the patientâ€™s
                    clinical response. Intravenous antibiotic therapy is almost always required initially, but oral
                    antibiotic therapy is usually preferred to complete the treatment course</li>
                <li>To cure chronic osteomyelitis, surgical debridement of necrotic bone and sequestra is essential</li>
                <li>Collect blood samples for culture because more than 50% of patients with vertebral or acute
                    long-bone osteomyelitis have bacteraemia. To increase blood culture yield, adults should have two
                    sets of samples (ie four bottles) collected. If blood culture results are positive, bone biopsy is
                    generally unnecessary. However, if no organism, or an organism of questionable significance (eg a
                    commensal organism such as a coagulase-negative staphylococcus), is identified, it is critical to
                    collect suitable samples of bone or pus for culture and histopathology. These samples should be
                    collected by radiologically guided percutaneous or open biopsy.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on osteomyelitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteomyelitis, adult, MILD pen all, VERTEBRAL, MRSA negative -->
    <div data-role="page" id="osteo2a2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult vertebral osteomyelitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn20">Adult vertebra osteomyelitis with no MRSA and non-severe penicillin
                hypersensitivity should be treated with:</h3>
            <h4 class="mrgn20b biteSpecial">
                <span class="font15">Withhold antibiotic therapy until a microbiological diagnosis is made in all adults
                    who have a normal neurological examination. <br><br> Only treat empirically with the treatment below
                    if microbiological diagnosis cannot be made.
                </span>
            </h4>
            <br>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefazolin 2 g intravenously, 8-hourly</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>Contact infectious diseases if the patient has suspected gram negative infection</li>
                <li>This regimen is for both acute and chronic osteomyelitis until a microbiological diagnosis is made.
                    Obtain diagnostic samples before antibiotic therapy is started. Once a microbiological diagnosis is
                    made, modify therapy accordingly</li>
                <li>If the patient is septic please treat as per <a href="sepsisNsimilar.html#sepsis">sepsis</a>
                    treatment pathway</li>
                <li>For adults or children with osteomyelitis associated with prosthetic material, seek expert advice
                </li>
                <li>Prolonged antibiotic therapy is required to cure osteomyelitis. The duration of therapy depends on
                    the patientâ€™s age, whether the infection is acute or chronic, the pathogen and the patientâ€™s
                    clinical response. Intravenous antibiotic therapy is almost always required initially, but oral
                    antibiotic therapy is usually preferred to complete the treatment course</li>
                <li>To cure chronic osteomyelitis, surgical debridement of necrotic bone and sequestra is essential</li>
                <li>Collect blood samples for culture because more than 50% of patients with vertebral or acute
                    long-bone osteomyelitis have bacteraemia. To increase blood culture yield, adults should have two
                    sets of samples (ie four bottles) collected. If blood culture results are positive, bone biopsy is
                    generally unnecessary. However, if no organism, or an organism of questionable significance (eg a
                    commensal organism such as a coagulase-negative staphylococcus), is identified, it is critical to
                    collect suitable samples of bone or pus for culture and histopathology. These samples should be
                    collected by radiologically guided percutaneous or open biopsy.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on osteomyelitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteomyelitis, adult, bad pen all, OR MRSA, VERTEBRAL, -->
    <div data-role="page" id="osteo3a2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult vertebral osteomyelitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn20">For adult vertebral osteomyelitis with severe penicillin hypersensitivity
                and no MRSA risk factors treat with:</h3>
            <h4 class="mrgn20b biteSpecial">
                <span class="font15">Withhold antibiotic therapy until a microbiological diagnosis is made in all adults
                    who have a normal neurological examination. <br><br> Only treat empirically with the treatment below
                    if microbiological diagnosis cannot be made.
                </span>
            </h4>
            <br>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per the nomogram below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>ost</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Contact infectious diseases if the patient has suspected gram negative infection</li>
                <li>This regimen is for both acute and chronic osteomyelitis until a microbiological diagnosis is made.
                    Obtain diagnostic samples before antibiotic therapy is started. Once a microbiological diagnosis is
                    made, modify therapy accordingly</li>
                <li>If the patient is septic please treat as per <a href="sepsisNsimilar.html#sepsis">sepsis</a>
                    treatment pathway</li>
                <li>For adults or children with osteomyelitis associated with prosthetic material, seek expert advice
                </li>
                <li>Prolonged antibiotic therapy is required to cure osteomyelitis. The duration of therapy depends on
                    the patientâ€™s age, whether the infection is acute or chronic, the pathogen and the patientâ€™s
                    clinical response. Intravenous antibiotic therapy is almost always required initially, but oral
                    antibiotic therapy is usually preferred to complete the treatment course</li>
                <li>To cure chronic osteomyelitis, surgical debridement of necrotic bone and sequestra is essential</li>
                <li>Collect blood samples for culture because more than 50% of patients with vertebral or acute
                    long-bone osteomyelitis have bacteraemia. To increase blood culture yield, adults should have two
                    sets of samples (ie four bottles) collected. If blood culture results are positive, bone biopsy is
                    generally unnecessary. However, if no organism, or an organism of questionable significance (eg a
                    commensal organism such as a coagulase-negative staphylococcus), is identified, it is critical to
                    collect suitable samples of bone or pus for culture and histopathology. These samples should be
                    collected by radiologically guided percutaneous or open biopsy.</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Actual body<br> weight &#40;kg&#41;</th>
                        <th>CrClr <br>&lt; 20 mL/min</th>
                        <th>CrClr <br>20-60 mL/min</th>
                        <th>CrClr <br>&gt; 60 mL/min</th>
                        <th class="bg-success">Administer over<sup>(1)</sup></th>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on osteomyelitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of HAP MDR YES, Penicillin BAD, ?MRSA #hap2b -->
    <div data-role="page" id="osteox" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Vertebral Osteomyelitis treatment</h1>
        </div>
        <br>
        <!-- /header -->
        <div class="container-fluid">
            <h4 class="color-danger mrgn15b">If a patient with vertebral osteomyelitis has MRSA risk factors then
                treatment is complex. Contact infectious diseases for advice</h4>
        </div>
        <hr>
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on osteomyelitis</a> - Antibiotic Expert Groups. Therapeutic guidelines:
                antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteox -->



    <!-- Start of osteomyelitis, adult, no pen all, vertebral, neuro compromise -->
    <div data-role="page" id="osteo1a2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult vertebral osteomyelitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn20">For adult vertebral osteomyelitis with neurological compromise and no
                penicillin allergy treat with:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Flucloxacillin 2 g IV, 6-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per the nomogram below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g IV, 12-hourly.</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>ost</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 4<script> document.write(getCode())</script>ost</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>FOUR</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past four days. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr />
            <ul class="line30">
                <li>If there is only a single line it is best to give the other antibiotics before starting vancomycin
                    as vancomycin has a lengthy infusion time</li>
                <li>This regimen is for both acute and chronic osteomyelitis until a microbiological diagnosis is made.
                    Obtain diagnostic samples as soon as possible. Once a microbiological diagnosis is made, modify
                    therapy accordingly</li>
                <li>If the patient is septic please treat as per <a href="sepsisNsimilar.html#sepsis">sepsis</a>
                    treatment pathway</li>
                <li>For adults or children with osteomyelitis associated with prosthetic material, seek expert advice
                </li>
                <li>Prolonged antibiotic therapy is required to cure osteomyelitis. The duration of therapy depends on
                    the patientâ€™s age, whether the infection is acute or chronic, the pathogen and the patientâ€™s
                    clinical response. Intravenous antibiotic therapy is almost always required initially, but oral
                    antibiotic therapy is usually preferred to complete the treatment course</li>
                <li>To cure chronic osteomyelitis, surgical debridement of necrotic bone and sequestra is essential</li>
                <li>Collect blood samples for culture because more than 50% of patients with vertebral or acute
                    long-bone osteomyelitis have bacteraemia. To increase blood culture yield, adults should have two
                    sets of samples (ie four bottles) collected. If blood culture results are positive, bone biopsy is
                    generally unnecessary. However, if no organism, or an organism of questionable significance (eg a
                    commensal organism such as a coagulase-negative staphylococcus), is identified, it is critical to
                    collect suitable samples of bone or pus for culture and histopathology. These samples should be
                    collected by radiologically guided percutaneous or open biopsy.</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Actual body<br> weight &#40;kg&#41;</th>
                        <th>CrClr <br>&lt; 20 mL/min</th>
                        <th>CrClr <br>20-60 mL/min</th>
                        <th>CrClr <br>&gt; 60 mL/min</th>
                        <th class="bg-success">Administer over<sup>(1)</sup></th>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on osteomyelitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteomyelitis, adult, MILD pen all, vertebral, neuro compromise -->
    <div data-role="page" id="osteo2a2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult vertebral osteomyelitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn20">For adult vertebral osteomyelitis with neurological compromise and
                non-severe penicillin hypersensitivity treat with:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g IV, 12-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per the nomogram below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>ost</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 4<script> document.write(getCode())</script>ost</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>FOUR</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past four days. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr />
            <ul class="line30">
                <li>If there is only a single line it is best to give the ceftriaxone before starting vancomycin as
                    vancomycin has a lengthy infusion time</li>
                <li>This regimen is for both acute and chronic osteomyelitis until a microbiological diagnosis is made.
                    Obtain diagnostic samples as soon as possible. Once a microbiological diagnosis is made, modify
                    therapy accordingly</li>
                <li>If the patient is septic please treat as per <a href="sepsisNsimilar.html#sepsis">sepsis</a>
                    treatment pathway</li>
                <li>For adults or children with osteomyelitis associated with prosthetic material, seek expert advice
                </li>
                <li>Prolonged antibiotic therapy is required to cure osteomyelitis. The duration of therapy depends on
                    the patientâ€™s age, whether the infection is acute or chronic, the pathogen and the patientâ€™s
                    clinical response. Intravenous antibiotic therapy is almost always required initially, but oral
                    antibiotic therapy is usually preferred to complete the treatment course</li>
                <li>To cure chronic osteomyelitis, surgical debridement of necrotic bone and sequestra is essential</li>
                <li>Collect blood samples for culture because more than 50% of patients with vertebral or acute
                    long-bone osteomyelitis have bacteraemia. To increase blood culture yield, adults should have two
                    sets of samples (ie four bottles) collected. If blood culture results are positive, bone biopsy is
                    generally unnecessary. However, if no organism, or an organism of questionable significance (eg a
                    commensal organism such as a coagulase-negative staphylococcus), is identified, it is critical to
                    collect suitable samples of bone or pus for culture and histopathology. These samples should be
                    collected by radiologically guided percutaneous or open biopsy.</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Actual body<br> weight &#40;kg&#41;</th>
                        <th>CrClr <br>&lt; 20 mL/min</th>
                        <th>CrClr <br>20-60 mL/min</th>
                        <th>CrClr <br>&gt; 60 mL/min</th>
                        <th class="bg-success">Administer over<sup>(1)</sup></th>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on osteomyelitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- Start of osteomyelitis, adult, BAD pen all, vertebral, neuro compromise -->
    <div data-role="page" id="osteo3a2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult vertebral osteomyelitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn20">For adult vertebral osteomyelitis with neurological compromise and severe
                penicillin hypersensitivity treat with:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 400 mg intravenously, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, as per the nomogram below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>ost</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ciprofloxacin IV is:</span>
                <span class="font15 bold"> 4<script> document.write(getCode())</script>ost</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>FOUR</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if treatment is to continue past four days. Please
                    annotate this code on the medication chart and document when infectious diseases are to be contacted
                    in the patient notes.
                </div>
            </h4>
            <hr />
            <ul class="line30">
                <li>If there is only a single line it is best to give the ciprofloxacin before starting vancomycin as
                    vancomycin has a lengthy infusion time</li>
                <li>This regimen is for both acute and chronic osteomyelitis until a microbiological diagnosis is made.
                    Obtain diagnostic samples as soon as possible. Once a microbiological diagnosis is made, modify
                    therapy accordingly</li>
                <li>If the patient is septic please treat as per <a href="sepsisNsimilar.html#sepsis">sepsis</a>
                    treatment pathway</li>
                <li>For adults or children with osteomyelitis associated with prosthetic material, seek expert advice
                </li>
                <li>Prolonged antibiotic therapy is required to cure osteomyelitis. The duration of therapy depends on
                    the patientâ€™s age, whether the infection is acute or chronic, the pathogen and the patientâ€™s
                    clinical response. Intravenous antibiotic therapy is almost always required initially, but oral
                    antibiotic therapy is usually preferred to complete the treatment course</li>
                <li>To cure chronic osteomyelitis, surgical debridement of necrotic bone and sequestra is essential</li>
                <li>Collect blood samples for culture because more than 50% of patients with vertebral or acute
                    long-bone osteomyelitis have bacteraemia. To increase blood culture yield, adults should have two
                    sets of samples (ie four bottles) collected. If blood culture results are positive, bone biopsy is
                    generally unnecessary. However, if no organism, or an organism of questionable significance (eg a
                    commensal organism such as a coagulase-negative staphylococcus), is identified, it is critical to
                    collect suitable samples of bone or pus for culture and histopathology. These samples should be
                    collected by radiologically guided percutaneous or open biopsy.</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Actual body<br> weight &#40;kg&#41;</th>
                        <th>CrClr <br>&lt; 20 mL/min</th>
                        <th>CrClr <br>20-60 mL/min</th>
                        <th>CrClr <br>&gt; 60 mL/min</th>
                        <th class="bg-success">Administer over<sup>(1)</sup></th>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on osteomyelitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /osteo -->

    <!-- LET THE SEPTIC ARTHRITIS MAZE BEGIN -->


    <!-- Start of septic arthritis page: #septar -->
    <div data-role="page" id="septar" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical Septic Arthritis Treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h4 class="mrgn20b biteSpecial">
                <span class="font15">Please note this section is for empiric treatment of septic arthritis <u>before</u>
                    results of culture.<br>Take diagnostic samples before starting antibiotic therapy
                </span>
            </h4>
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#septar1">No penicillin allergy</a></li>
                <li><a href="#septar2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#septar1b1">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patientâ€™s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /septar -->

    <!-- Start of septic arthritis page: #septar1 -->
    <div data-role="page" id="septar1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empiric Septic Arthritis Treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the septic arthritis associated with a diabetic foot or leg ulcer or
                    vascular insufficiency?</span>

            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="skinNsoftTissue.html#diabf3">Yes &#40;treat as diabetic foot&#41;</a></li>
                <li><a href="#septar1b">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /septar1 -->

    <!-- Start of septic arthritis page: #septar2 -->
    <div data-role="page" id="septar2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empiric Septic Arthritis Treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the septic arthritis associated with a diabetic foot or leg ulcer or
                    vascular insufficiency?</span>

            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="skinNsoftTissue.html#diabf1">Yes &#40;treat as diabetic foot&#41;</a></li>
                <li><a href="#septar2b">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /septar2 -->

    <!-- Start of septic arthritis ?MRSA #septar1b -->
    <div data-role="page" id="septar1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empiric Septic Arthritis Treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the patient at risk of methicillin-resistant Staphylococcus aureus
                &#40;MRSA&#41; infection?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#septar1b1">Yes</a></li>
                <li><a href="#septar1b2">No</a></li>
            </ul>
            <hr />
            <ul type=circle>
                <li>Risk factors for MRSA infection include;
                    <ul>
                        <li>residence in an area with a high prevalence of MRSA &#40;e.g. Regions north of metropolitan Perth in Western Australia, especially the Kimberly and Pilbara; Northern Territory and remote communities in northern Queensland;&#41;</li>
                        <li>known or suspected to be colonised with methicillin-resistant <i>Staphylococcus aureus</i>
                            &#40;MRSA&#41;</li>
                        <li>previous colonisation or infection with MRSA, particularly if recent or associated with the
                            current episode of care</li>
                        <li>frequent stays, or a current prolonged stay, in a hospital with a high prevalence of MRSA,
                            particularly if associated with antibiotic exposure or recent surgery</li>
                        <li>residence in an aged-care facility with a high prevalence of MRSA, particularly if the
                            patient has had multiple courses of antibiotics.</li>
                        <li>an intravascular catheter-related infection in a unit with a significant incidence of MRSA
                            infection</li>
                    </ul>
                </li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /septar1b -->

    <!-- Start of septic arthritis ?MRSA #septar2b -->
    <div data-role="page" id="septar2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empiric Septic Arthritis Treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the patient at risk of methicillin-resistant Staphylococcus aureus
                &#40;MRSA&#41; infection?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#septar1b1">Yes</a></li>
                <li><a href="#septar2b2">No</a></li>
            </ul>
            <hr />
            <ul type=circle>
                <li>Risk factors for MRSA infection include;
                    <ul>
                        <li>residence in an area with a high prevalence of MRSA &#40;e.g. Regions north of metropolitan Perth in Western Australia, especially the Kimberly and Pilbara; Northern Territory and remote communities in northern Queensland;&#41;</li>
                        <li>known or suspected to be colonised with methicillin-resistant <i>Staphylococcus aureus</i>
                            &#40;MRSA&#41;</li>
                        <li>previous colonisation or infection with MRSA, particularly if recent or associated with the
                            current episode of care</li>
                        <li>frequent stays, or a current prolonged stay, in a hospital with a high prevalence of MRSA,
                            particularly if associated with antibiotic exposure or recent surgery</li>
                        <li>residence in an aged-care facility with a high prevalence of MRSA, particularly if the
                            patient has had multiple courses of antibiotics.</li>
                        <li>an intravascular catheter-related infection in a unit with a significant incidence of MRSA
                            infection</li>
                    </ul>
                </li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /septar2b -->

    <!-- Start of septic arthritis treatment, no allergy, no MRSA: #septar1b2 -->
    <div data-role="page" id="septar1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empiric Septic Arthritis Treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For empirical therapy in a patient with no penicillin allergy and no MRSA
                risk factors, while awaiting the results of cultures and susceptibility use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Flucloxacillin 2 g &#40;child 50 mg/kg up to 2 g&#41; IV, 6-hourly</span>
                </h4>
            </div>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="3">Suggested Antibiotic Duration for Septic Arthritis</th>
                    </tr>
                    <tr>
                        <td><b>Patient age</b></td>
                        <td><b>Intravenous &#40;minimum&#41;</b></td>
                        <td><b>Total &#40;intravenous + oral&#41;</b></td>
                    </tr>
                    <tr>
                        <td>neonate</td>
                        <td>3 weeks</td>
                        <td>3 weeks &#40;all intravenously&#41;</td>
                    </tr>
                    <tr>
                        <td>child</td>
                        <td>3 days</td>
                        <td>3 weeks</td>
                    </tr>
                    <tr>
                        <td>adult</td>
                        <td>2 weeks</td>
                        <td>4 weeks</td>
                    </tr>
                </table>
            </div>
            <hr>
            <ul class="line30">
                <li>The durations of therapy suggested in this table should be modified according to clinical response.
                </li>
                <li>These treatment durations do not apply to gonococcal arthritis, which should be treated for a total
                    of 7 days.</li>
                <li>If the patient is clinically improving, an earlier switch to oral therapy may be possible, as long
                    as there is an appropriate oral antimicrobial available that is as effective as intravenous therapy
                    (eg ciprofloxacin, clindamycin). Conversely, some patients need a longer duration of intravenous
                    therapy than recommended in this table. Seek expert advice.</li>
            </ul>
            <hr>
            <ul class="line30">
                <li>Take diagnostic samples before starting antibiotic therapy to exclude alternative or coexisting
                    diagnoses (such as an acute crystal arthropathy) and enable antibiotic therapy to be directed.
                    Appropriate diagnostic samples include blood for culture, and a joint aspirate for Gram stain,
                    culture and microscopy.</li>
                <li>Joint aspiration should be performed by experienced clinicians, using an aseptic technique. When
                    performing diagnostic aspiration, aspirating the bulk of the effusion can offer therapeutic
                    benefits. Aspiration should be as complete as possible without compromising patient comfort or
                    causing damage to the joint.</li>
                <li>Acute rheumatic fever may present as an acute monoarthritis and should be excluded, particularly in
                    Aboriginal and Torres Strait Islander people living in rural or remote settings, and other
                    populations who may be at high risk (eg Aboriginal and Torres Strait Islander people living in urban
                    settings, Maori and Pacific Islander people.</li>
                <li>If the patient has a postoperative infection of a prosthetic shoulder joint please contact
                    infectious diseases for advice before starting treatment. Management is complex.</li>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous
                    heritage, previous MRSA colonisation and line associated infection</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on Septic Arthritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /septar1b2 -->

    <!-- Start of septic arthritis treatment, no allergy, no MRSA: #septar2b2 -->
    <div data-role="page" id="septar2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empiric Septic Arthritis Treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For empirical therapy in a patient with non-severe penicillin
                hypersensitivity and no MRSA risk factors, while awaiting the results of cultures and susceptibility
                use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefazolin 2 g &#40;child 50 mg/kg up to 2 g&#41; IV, 8-hourly</span>
                </h4>
            </div>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="3">Suggested Antibiotic Duration for Septic Arthritis</th>
                    </tr>
                    <tr>
                        <td><b>Patient age</b></td>
                        <td><b>Intravenous &#40;minimum&#41;</b></td>
                        <td><b>Total &#40;intravenous + oral&#41;</b></td>
                    </tr>
                    <tr>
                        <td>neonate</td>
                        <td>3 weeks</td>
                        <td>3 weeks &#40;all intravenously&#41;</td>
                    </tr>
                    <tr>
                        <td>child</td>
                        <td>3 days</td>
                        <td>3 weeks</td>
                    </tr>
                    <tr>
                        <td>adult</td>
                        <td>2 weeks</td>
                        <td>4 weeks</td>
                    </tr>
                </table>
            </div>
            <hr>
            <ul class="line30">
                <li>The durations of therapy suggested in this table should be modified according to clinical response.
                </li>
                <li>These treatment durations do not apply to gonococcal arthritis, which should be treated for a total
                    of 7 days.</li>
                <li>If the patient is clinically improving, an earlier switch to oral therapy may be possible, as long
                    as there is an appropriate oral antimicrobial available that is as effective as intravenous therapy
                    (eg ciprofloxacin, clindamycin). Conversely, some patients need a longer duration of intravenous
                    therapy than recommended in this table. Seek expert advice.</li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Take diagnostic samples before starting antibiotic therapy to exclude alternative or coexisting
                    diagnoses (such as an acute crystal arthropathy) and enable antibiotic therapy to be directed.
                    Appropriate diagnostic samples include blood for culture, and a joint aspirate for Gram stain,
                    culture and microscopy.</li>
                <li>Joint aspiration should be performed by experienced clinicians, using an aseptic technique. When
                    performing diagnostic aspiration, aspirating the bulk of the effusion can offer therapeutic
                    benefits. Aspiration should be as complete as possible without compromising patient comfort or
                    causing damage to the joint.</li>
                <li>Acute rheumatic fever may present as an acute monoarthritis and should be excluded, particularly in
                    Aboriginal and Torres Strait Islander people living in rural or remote settings, and other
                    populations who may be at high risk (eg Aboriginal and Torres Strait Islander people living in urban
                    settings, Maori and Pacific Islander people.</li>
                <li>If the patient has a postoperative infection of a prosthetic shoulder joint please contact
                    infectious diseases for advice before starting treatment. Management is complex.</li>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous
                    heritage, previous MRSA colonisation and line associated infection</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on Septic Arthritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /septar2b2 -->

    <!-- Start of septic arthritis treatment, no allergy but MRSA or bad allergy: #septar1b1 -->
    <div data-role="page" id="septar1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empiric Septic Arthritis Treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For empirical therapy in a patient with either severe penicillin allergy
                and/or a patient with MRSA risk factors, while awaiting the results of cultures and susceptibility use:
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin as per nomograms below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <br/>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="3">Suggested Antibiotic Duration for Septic Arthritis</th>
                    </tr>
                    <tr>
                        <td><b>Patient age</b></td>
                        <td><b>Intravenous &#40;minimum&#41;</b></td>
                        <td><b>Total &#40;intravenous + oral&#41;</b></td>
                    </tr>
                    <tr>
                        <td>neonate</td>
                        <td>3 weeks</td>
                        <td>3 weeks &#40;all intravenously&#41;</td>
                    </tr>
                    <tr>
                        <td>child</td>
                        <td>3 days</td>
                        <td>3 weeks</td>
                    </tr>
                    <tr>
                        <td>adult</td>
                        <td>2 weeks</td>
                        <td>4 weeks</td>
                    </tr>
                </table>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cac</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if IV treatment is to continue past 48 hours.
                    Please annotate this code on the medication chart and document when infectious diseases are to be
                    contacted in the patient notes.
                </div>
            </h4>
            <hr>
            <ul class="line30">
                <li>Take diagnostic samples before starting antibiotic therapy to exclude alternative or coexisting
                    diagnoses (such as an acute crystal arthropathy) and enable antibiotic therapy to be directed.
                    Appropriate diagnostic samples include blood for culture, and a joint aspirate for Gram stain,
                    culture and microscopy.</li>
                <li>Joint aspiration should be performed by experienced clinicians, using an aseptic technique. When
                    performing diagnostic aspiration, aspirating the bulk of the effusion can offer therapeutic
                    benefits. Aspiration should be as complete as possible without compromising patient comfort or
                    causing damage to the joint.</li>
                <li>Acute rheumatic fever may present as an acute monoarthritis and should be excluded, particularly in
                    Aboriginal and Torres Strait Islander people living in rural or remote settings, and other
                    populations who may be at high risk (eg Aboriginal and Torres Strait Islander people living in urban
                    settings, Maori and Pacific Islander people.</li>
                <li>If the patient has a postoperative infection of a prosthetic shoulder joint please contact
                    infectious diseases for advice before starting treatment. Management is complex.</li>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous
                    heritage, previous MRSA colonisation and line associated infection</li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr>
            <h4 class="color-primary mrgn20">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="bold color-danger">Red Man</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on Septic Arthritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /septar2b2 -->
    <!-- SEPTIC ARTHRITIS MAZE ENDS -->

        <!-- SEPTIC BURSITIS MAZE BEGINS -->

    <!-- Start of SEPTIC BURSITIS, ?PEN ALLERGY -->
    <div data-role="page" id="sepbur" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#sepbur1">No penicillin allergy</a></li>
                <li><a href="#sepbur2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#sepbur3">Severe immediate or delayed penicillin hypersensitivity</a></li>    
            </ul>
            <hr/>
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class ="bold">No penicillin allergy</p>
                <ul class="line30">
                    <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                    <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to prescribe penicillin class antibiotics &#40;with the patientâ€™s knowledge&#41;, and if required, use strategies for symptom control such as metoclopramide</li>
                </ul>
            <p class ="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes non-severe reactions such as isolated rash.</li>
                    <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>        
            <p class ="bold">Severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your patient has a history of these, contact infectious diseases for advice</li>
                </ul>
                <hr>
            <p class ="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours) involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing, swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class ="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:</div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope, incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain, vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class ="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30 percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41; or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur -->


    <!-- Start of SEPTIC BURSITIS, NO PEN ALLERGY  -->
    <div data-role="page" id="sepbur1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the patient have any systemic symptoms?</h3>
            <br/>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#sepbur1a">Yes</a></li>
                <li><a href="#sepbur1b">No</a></li>
            </ul> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur1 -->

    <!-- Start of SEPTIC BURSITIS, MILD PEN ALLERGY  -->
    <div data-role="page" id="sepbur2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the patient have any systemic symptoms?</h3>
            <br/>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#sepbur2a">Yes</a></li>
                <li><a href="#sepbur2b">No</a></li>
            </ul> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur2 -->

    <!-- Start of SEPTIC BURSITIS, BAD PEN ALLERGY  -->
    <div data-role="page" id="sepbur3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the patient have any systemic symptoms?</h3>
            <br/>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#sepbur3a">Yes</a></li>
                <li><a href="#sepbur3b">No</a></li>
            </ul> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur3 -->

    <!-- Start of SEPTIC BURSITIS, BAD PEN ALLERGY  -->
    <div data-role="page" id="sepbur1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the patient have any systemic symptoms?</h3>
            <br/>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#sepbur3a">Yes</a></li>
                <li><a href="#sepbur3b">No</a></li>
            </ul> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur3 -->

    <!-- Start of SEPTIC BURSITIS, NO PEN ALLERGY, SYSTEMIC, ?MRSA -->
    <div data-role="page" id="sepbur1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is methicillin-resistant Staphylococcus aureus (MRSA) infection suspected or is the patient at increased risk of MRSA?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#sepbur1a1">Yes</a></li>
                <li><a href="#sepbur1a2">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur1a -->

    <!-- Start of SEPTIC BURSITIS, NO PEN ALLERGY, NO SYSTEMIC, ?MRSA -->
    <div data-role="page" id="sepbur1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is methicillin-resistant Staphylococcus aureus (MRSA) infection suspected or is the patient at increased risk of MRSA?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#sepbur1b1">Yes</a></li>
                <li><a href="#sepbur1b2">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur1b -->

        <!-- Start of SEPTIC BURSITIS, NO PEN ALLERGY, SYSTEMIC, ?MRSA -->
    <div data-role="page" id="sepbur1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is methicillin-resistant Staphylococcus aureus (MRSA) infection suspected or is the patient at increased risk of MRSA?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#sepbur1a1">Yes</a></li>
                <li><a href="#sepbur1a2">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur1a -->

    <!-- Start of SEPTIC BURSITIS, NO PEN ALLERGY, NO SYSTEMIC, ?MRSA -->
    <div data-role="page" id="sepbur1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is methicillin-resistant Staphylococcus aureus (MRSA) infection suspected or is the patient at increased risk of MRSA?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#sepbur1b1">Yes</a></li>
                <li><a href="#sepbur1b2">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur1b -->

    <!-- Start of SEPTIC BURSITIS, MILD PEN ALLERGY, SYSTEMIC, ?MRSA -->
    <div data-role="page" id="sepbur2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is methicillin-resistant Staphylococcus aureus (MRSA) infection suspected or is the patient at increased risk of MRSA?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#sepbur1a1">Yes</a></li>
                <li><a href="#sepbur2a2">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur1a -->

    <!-- Start of SEPTIC BURSITIS, MILD PEN ALLERGY, NO SYSTEMIC, ?MRSA -->
    <div data-role="page" id="sepbur2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is methicillin-resistant Staphylococcus aureus (MRSA) infection suspected or is the patient at increased risk of MRSA?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#sepbur1b1">Yes</a></li>
                <li><a href="#sepbur2b2">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur2b -->

    <!-- Start of SEPTIC BURSITIS, BAD PEN ALLERGY, SYSTEMIC, ?MRSA -->
    <div data-role="page" id="sepbur3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is methicillin-resistant Staphylococcus aureus (MRSA) infection suspected or is the patient at increased risk of MRSA?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#sepbur1a1">Yes</a></li>
                <li><a href="#sepbur3a2">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur3a -->

    <!-- Start of SEPTIC BURSITIS, BAD PEN ALLERGY, NO SYSTEMIC, ?MRSA -->
    <div data-role="page" id="sepbur3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is methicillin-resistant Staphylococcus aureus (MRSA) infection suspected or is the patient at increased risk of MRSA?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#sepbur1b1">Yes</a></li>
                <li><a href="#sepbur3b2">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur3b -->

    <!-- Start of SEPTIC BURSITIS, NO PEN ALLERGY, YES SYSTEMIC, YES MRSA  -->
    <div data-role="page" id="sepbur1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">For a patient who is displaying systemic symptoms of infection, and at risk of MRSA infection give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin as per nomograms below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>bur</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if IV treatment is to continue past 48 hours.
                    Please annotate this code on the medication chart and document when infectious diseases are to be
                    contacted in the patient notes.
                </div>
            </h4>
            <hr>
            <ul type=circle>
                <li>Bursitis is most commonly noninfective. Septic bursitis is usually caused by Staphylococcus aureus and often follows local trauma. The usual sites of infection are the prepatellar and olecranon bursae. When there are signs of infection, confirm the diagnosis by microscopic examination and culture of a bursal aspirate. If the joint is involved, see <a href="#septar">septic arthritis</a></li>
                <li>If clinical improvement is delayed, repeated aspiration, catheter drainage or surgical excision may be required. When the patient is clinically improving (usually 3 to 7 days), switch to oral therapy as for septic bursitis without systemic symptoms and continue until the resolution of symptoms (usually 2 weeks).</li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr>
            <h4 class="color-primary mrgn20">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="bold color-danger">Red Man</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr/>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post septic bursitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur1a1 -->

    <!-- Start of SEPTIC BURSITIS, NO PEN ALLERGY, YES SYSTEMIC, NO MRSA  -->
    <div data-role="page" id="sepbur1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">For a patient with no penicillin allergy, who is displaying systemic symptoms of infection, not at risk of MRSA infection give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Flucloxacillin 2 g (child: 50 mg/kg up to 2 g) intravenously, 6-hourly</span>
                </h4>
            </div>
            <hr>
            <ul type=circle>
                <li>Bursitis is most commonly noninfective. Septic bursitis is usually caused by Staphylococcus aureus and often follows local trauma. The usual sites of infection are the prepatellar and olecranon bursae. When there are signs of infection, confirm the diagnosis by microscopic examination and culture of a bursal aspirate. If the joint is involved, see <a href="#septar">septic arthritis</a></li>
                <li>If clinical improvement is delayed, repeated aspiration, catheter drainage or surgical excision may be required. When the patient is clinically improving (usually 3 to 7 days), switch to oral therapy as for septic bursitis without systemic symptoms and continue until the resolution of symptoms (usually 2 weeks).</li>
            </ul>
            <hr/>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post septic bursitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur1a2 -->

    <!-- Start of SEPTIC BURSITIS, NO PEN ALLERGY, NO SYSTEMIC, YES MRSA  -->
    <div data-role="page" id="sepbur1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">For a patient who is not displaying systemic symptoms of infection, at risk of MRSA infection give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Doxycycline orally, 12-hourly</span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">100 mg </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child 8 years or older and less than 26 kg: &nbsp;</span>
                                </td>
                                <td><span class="color-purple"> 50 mg </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child 8 years or older and 26 to 35 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 75 mg</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child 8 years or older and more than 35 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 100 mg</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+sulfamethoxazole 320+1600 mg (child 1 month or older: 8+40 mg/kg up to 320+1600 mg) orally, 12-hourly</span>
                </h4>
            </div>
            <hr>
            <ul type=circle>
                <li>Bursitis is most commonly noninfective. Septic bursitis is usually caused by Staphylococcus aureus and often follows local trauma. The usual sites of infection are the prepatellar and olecranon bursae. When there are signs of infection, confirm the diagnosis by microscopic examination and culture of a bursal aspirate. If the joint is involved, see <a href="#septar">septic arthritis</a></li>
                <li>Continue treatment until infection has clinically resolved (usually 2 weeks). If infection is not improving after 48 hours of oral therapy, start intravenous therapy as for septic bursitis with systemic symptoms, and consider repeated aspiration or catheter drainage</li>
            </ul>
            <hr/>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post septic bursitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur1b1 -->

    <!-- Start of SEPTIC BURSITIS, NO PEN ALLERGY, NO SYSTEMIC, NO MRSA  -->
    <div data-role="page" id="sepbur1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">For a patient with no penicillin allergy, who is not displaying systemic symptoms of infection, not at risk of MRSA infection give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Flucloxacillin 1 g (child: 25 mg/kg up to 1 g) orally, 6-hourly</span>
                </h4>
            </div>
            <hr>
            <ul type=circle>
                <li>Bursitis is most commonly noninfective. Septic bursitis is usually caused by Staphylococcus aureus and often follows local trauma. The usual sites of infection are the prepatellar and olecranon bursae. When there are signs of infection, confirm the diagnosis by microscopic examination and culture of a bursal aspirate. If the joint is involved, see <a href="#septar">septic arthritis</a></li>
                <li>Continue treatment until infection has clinically resolved (usually 2 weeks). If infection is not improving after 48 hours of oral therapy, start intravenous therapy as for septic bursitis with systemic symptoms, and consider repeated aspiration or catheter drainage</li>
            </ul>
            <hr/>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post septic bursitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur1b2 -->

    <!-- Start of SEPTIC BURSITIS, MILD PEN ALLERGY, YES SYSTEMIC, NO MRSA  -->
    <div data-role="page" id="sepbur2a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">For a patient with non-severe penicillin allergy, who is displaying systemic symptoms of infection, not at risk of MRSA infection give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefazolin 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly.</span>
                </h4>
            </div>
            <hr>
            <ul type=circle>
                <li>Bursitis is most commonly noninfective. Septic bursitis is usually caused by Staphylococcus aureus and often follows local trauma. The usual sites of infection are the prepatellar and olecranon bursae. When there are signs of infection, confirm the diagnosis by microscopic examination and culture of a bursal aspirate. If the joint is involved, see <a href="#septar">septic arthritis</a></li>
                <li>If clinical improvement is delayed, repeated aspiration, catheter drainage or surgical excision may be required. When the patient is clinically improving (usually 3 to 7 days), switch to oral therapy as for septic bursitis without systemic symptoms and continue until the resolution of symptoms (usually 2 weeks).</li>
            </ul>
            <hr/>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post septic bursitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur1a2 -->

    <!-- Start of SEPTIC BURSITIS, MILD PEN ALLERGY, NO SYSTEMIC, NO MRSA  -->
    <div data-role="page" id="sepbur2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">For a patient with no penicillin allergy, who is not displaying systemic symptoms of infection, not at risk of MRSA infection give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefalexin 1 g (child: 25 mg/kg up to 1 g) orally, 6-hourly.</span>
                </h4>
            </div>
            <hr>
            <ul type=circle>
                <li>Bursitis is most commonly noninfective. Septic bursitis is usually caused by Staphylococcus aureus and often follows local trauma. The usual sites of infection are the prepatellar and olecranon bursae. When there are signs of infection, confirm the diagnosis by microscopic examination and culture of a bursal aspirate. If the joint is involved, see <a href="#septar">septic arthritis</a></li>
                <li>Continue treatment until infection has clinically resolved (usually 2 weeks). If infection is not improving after 48 hours of oral therapy, start intravenous therapy as for septic bursitis with systemic symptoms, and consider repeated aspiration or catheter drainage</li>
                <li>It is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use the treatment recommended for patients with immediate (nonsevere or severe) or delayed severe hypersensitivity</li>
            </ul>
            <hr/>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post septic bursitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur2b2 -->

    <!-- Start of SEPTIC BURSITIS, BAD PEN ALLERGY, YES SYSTEMIC, NO MRSA  -->
    <div data-role="page" id="sepbur3a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">For a patient with severe penicillin allergy, who is displaying systemic symptoms of infection, and at risk of MRSA infection give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin as per nomograms below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg (child: 15 mg/kg up to 600 mg) intravenously, 8-hourly</span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin or clindamycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>bur</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if IV treatment is to continue past 48 hours.
                    Please annotate this code on the medication chart and document when infectious diseases are to be
                    contacted in the patient notes.
                </div>
            </h4>
            <hr>
            <ul type=circle>
                <li>Bursitis is most commonly noninfective. Septic bursitis is usually caused by Staphylococcus aureus and often follows local trauma. The usual sites of infection are the prepatellar and olecranon bursae. When there are signs of infection, confirm the diagnosis by microscopic examination and culture of a bursal aspirate. If the joint is involved, see <a href="#septar">septic arthritis</a></li>
                <li>If clinical improvement is delayed, repeated aspiration, catheter drainage or surgical excision may be required. When the patient is clinically improving (usually 3 to 7 days), switch to oral therapy as for septic bursitis without systemic symptoms and continue until the resolution of symptoms (usually 2 weeks).</li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr>
            <h4 class="color-primary mrgn20">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="bold color-danger">Red Man</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr/>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post septic bursitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur3a2 -->

    <!-- Start of SEPTIC BURSITIS, BAD PEN ALLERGY, NO SYSTEMIC, NO MRSA  -->
    <div data-role="page" id="sepbur3b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Septic Bursitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">For a patient with severe penicillin allergy, who is not displaying systemic symptoms of infection, not at risk of MRSA infection give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 450 mg (child: 10 mg/kg up to 450 mg) orally, 8-hourly</span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for oral clindamycin is:</span>
                <span class="font15 bold"> 7<script> document.write(getCode())</script>bur</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>SEVEN</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if IV treatment is to continue past one week.
                    Please annotate this code on the medication chart and document when infectious diseases are to be
                    contacted in the patient notes.
                </div>
            </h4>
            <hr>
            <ul type=circle>
                <li>Bursitis is most commonly noninfective. Septic bursitis is usually caused by Staphylococcus aureus and often follows local trauma. The usual sites of infection are the prepatellar and olecranon bursae. When there are signs of infection, confirm the diagnosis by microscopic examination and culture of a bursal aspirate. If the joint is involved, see <a href="#septar">septic arthritis</a></li>
                <li>Continue treatment until infection has clinically resolved (usually 2 weeks). If infection is not improving after 48 hours of oral therapy, start intravenous therapy as for septic bursitis with systemic symptoms, and consider repeated aspiration or catheter drainage</li>
            </ul>
            <hr/>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post septic bursitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /sepbur3b2 -->

</body>
<script src="bootstrap/js/script.js"></script>
<script src="bootstrap/js/test.js"></script>
<script src="bootstrap/js/email.js"></script>

</html>